Government urged to revamp positive list system

Korea should revise the current positive list system so that domestic drug makers will be able to focus on research and development of new drugs to survive in an era of the free trade agreement, according to the Korea Pharmaceutical Manufacturers Association.

Under the current drug pricing system, new drugs undergo much stricter screening, conducted by the Health Insurance Review and Assessm...